Crispr Therapeutics shares owned by Boston Family Office
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Boston Family Office
from 13F filings
Historical chart of Boston Family Office investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Boston Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Boston Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $651k | 9.6k | 68.17 |
| 2023-12-31 | $598k | 9.6k | 62.62 |
| 2023-09-30 | $433k | 9.6k | 45.34 |
| 2023-06-30 | $536k | 9.6k | 56.13 |
| 2023-03-31 | $432k | 9.6k | 45.24 |
| 2022-12-31 | $388k | 9.6k | 40.63 |
| 2022-09-30 | $624k | 9.6k | 65.34 |
| 2022-06-30 | $580k | 9.6k | 60.73 |
| 2022-03-31 | $599k | 9.6k | 62.72 |
| 2021-12-31 | $724k | 9.6k | 75.81 |
| 2021-09-30 | $1.1M | 9.6k | 111.94 |
| 2021-06-30 | $1.5M | 9.6k | 161.88 |
| 2021-03-31 | $1.2M | 9.6k | 121.78 |
| 2020-12-31 | $1.6M | 10k | 153.11 |
| 2020-09-30 | $861k | 10k | 83.59 |
| 2020-06-30 | $757k | 10k | 73.50 |
| 2020-03-31 | $437k | 10k | 42.43 |
| 2019-12-31 | $627k | 10k | 60.87 |
| 2019-09-30 | $426k | 10k | 40.96 |
| 2019-06-30 | $490k | 10k | 47.12 |
| 2019-03-31 | $371k | 10k | 35.67 |
| 2018-12-31 | $297k | 10k | 28.56 |
| 2018-09-30 | $466k | 11k | 44.38 |
| 2018-06-30 | $611k | 10k | 58.75 |
| 2018-03-31 | $457k | 10k | 45.70 |